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Background
Although the immune recovery associated with highly
active antiretroviral therapy (HAART) in HIV infection
has important clinical benefits, this restoration of immu-
nity may result in deterioration, when HAART is initiated
in patients with tuberculosis (TB). The immune reconsti-
tution inflammatory syndrome (IRIS) has also been
reported in non-HIV persons following anti-TB treatment
(ATT). The incidence of IRIS in case-control studies on
HIV and non-HIV-infected patients, has been found to be
28-36% and 7-10%, respectively, depending on background
tuberculosis prevalence rates.
We report two cases illustrating IRIS in treated CNS
TB, one in a patient diagnosed with HIV stage C3 and
the second in a patient with immunosuppression due to
anti-tumor necrosis factor alpha treatment.
Case report
A 40 year-patient, HIV-infected, was diagnosed with
tuberculous meningoencephalitis (CSF with 210 elements,
lymphocytic predominance, protein of 2.1 g/L, glucose of
0.26 g/L; right hemiplegia and motor aphasia), due to
Mycobacterium tuberculosis susceptible to all anti-TB
agents. He initially improved under ATT, but one week
after antiretroviral therapy (ART) was started, at 6 weeks
after the initiation of ATT, he presented with worsening
of his symptoms (left hemiparesis and mixed aphasia), of
CSF and MRI changes. He improved after he was started
on corticosteroids (dexamethasone 24 mg/day initially,
then tapered doses), but was readmitted with recurrence
of the left hemiparesis and worsening aphasia, while redu-
cing the steroid dose to 8 mg of methylprednisolone. Wor-
sening of his neurological status has been reemerging each
time we try to stop steroids over a 6-month period.
The second case is a 60 year-old patient, with ankylosing
spondylitis, treated for 3 years with infliximab, diagnosed
with disseminated TB (multiple disseminated tuberculo-
mas and pulmonary TB) histological and bacteriological
confirmed. The initiation of ATT has led to neurological
improvement, but after 3 weeks of therapy the patient pre-
sented with fever and diplopia. These symptoms improved
only after corticosteroids administration (dexamethasone
16 mg/day initially, then tapered doses). At week 18 of
ATT the patient was still on steroids.
Conclusion
High doses of steroids are usually used to control the IRIS
symptoms in TB patients with CNS involvement, but the
dosing and duration of corticosteroids should be persona-
lized to each patient. Some patients may require extended
courses of corticosteroids.
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